The immune evasion paradox: Immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation

Journal of Virology

Volumn 82, Issue 23, 2008, Pages 11637-11650

  Böhm, Verena ^a   Simon, Christian O ^a   Podlech, Jürgen ^a   Seckert, Christof K ^a   Gendig, Dorothea ^a   Deegen, Petra ^a   Gillert Marien, Dorothea ^a   Lemmermann, Niels A W ^a   Holtappels, Rafaela ^a   Reddehase, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CD8+ T LYMPHOCYTE; CELL SELECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; GENE DELETION; GENE EXPRESSION; GOLGI COMPLEX; IMMUNOMODULATION; IMMUNOREACTIVITY; LYMPH NODE; LYSOSOME MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; FEMALE; GENOME, VIRAL; HERPESVIRIDAE INFECTIONS; IMMEDIATE-EARLY PROTEINS; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; LYMPH NODES; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; SPLEEN; VIRAL PROTEINS; VIRUS REPLICATION;

CYTOMEGALOVIRUS; MURID HERPESVIRUS 1;

EID: 56449103425     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01510-08     Document Type: Article

References (72)

1. Alcami, A., and U. H. Koszinowski. 2000. Viral mechanisms of immune evasion. Immunol. Today 9:447-455.
2. + dendritic cells but not by Langerhans cells. Science 301:1925-1928.
3. + T-cell responses are not affected by antigen load or the absence of perforin or gamma interferon. J. Virol. 82:4931-4937.
4. Andrews, D. M., C. E. Andoniou, F. Granucci, P. Ricciardi-Castagnoli, and M. A. Degli-Esposti. 2001. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2:1077-1084.
5. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323-1326.
6. + dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172:1996-2000.
7. Benedict, C. A., A. Loewendorf, Z. Garcia, B. R. Blazar, and E. M. Janssen. 2008. Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J. Immunol. 180:4836-4847.
8. Böhm, V., J. Podlech, D. Thomas, P. Deegen, M.-F. Pahl-Seibert, N. A. W. Lemmermann, N. K. A. Grzimek, S. A. Oehrlein-Karpi, M. J. Reddehase, and R. Holtappels. 2008. Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy. Med. Microbiol. Immunol. 197:135-144.
9. + T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4:579-585.
10. Bubic, I., M. Wagner, A. Krmpotic, T. Saulig, S. Kim, W. M. Yokoyama, S. Jonjic, and U. H. Koszinowski. 2004. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78:7536-7544.
11. Campbell, A. E., V. J. Cavanaugh, and J. S. Slater. 2008. The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med. Microbiol. Immunol. 197:205-213.
12. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548-551.
13. Dalod, M., T. Hamilton, R. Salomon, T. P. Salazar-Mather, S. C. Henry, J. D. Hamilton, and C. A. Biron. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 197:885-898.
14. del Val, M., H. Hengel, H. Haecker, U. Hartlaub, T. Ruppert, P. Lucin, and U. H. Koszinowski. 1992. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 176:729-738.
15. Doom, C. M., and A. B. Hill. 2008. MHC class I immune evasion in MCMV infection. Med. Microbiol. Immunol. 197:191-2004.
16. Gold, M. C., M. W. Munks, M. Wagner, U. H. Koszinowski, A. B. Hill, and S. P. Fling. 2002. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL, but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. J. Immunol. 169:359-365.
17. Gold, M. C., M. W. Munks, M. Wagner, C. W. McMahon, A. Kelly, D. G. Kavanagh, M. K. Slifka, U. H. Koszinowski, D. H. Raulet, and A. B. Hill. 2004. Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J. Immunol. 172:6944-6953.
18. Grzimek, N. K. A., J. Podlech, H.-P. Steffens, R. Holtappels, S. Schmalz, and M. J. Reddehase. 1999. In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus. J. Virol. 73:5043-5055.
19. Hanson, L. K., and A. E. Campbell. 2006. Determinants of macrophage tropism, p. 419-443. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, Norfolk, United Kingdom.
20. Heath, W. R., and F. R. Carbone. 2001. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1:126-134.
21. Heath, W. R., and F. R. Carbone. 2001. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:47-64.
22. Hengel, H., W. Brune, and U. H. Koszinowski. 1998. Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist. Trends Microbiol. 6:190-197.
23. Henrickson, S. E., T. R. Mempel, I. B. Mazo, B. Liu, M. N. Artymov, H. Zheng, A. Peixoto, M. P. Flynn, B. Senman, T. Junt, H. C. Wong, A. K. Chakraborty, and U. H. von Andrian. 2008. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat. Immunol. 9:282-291.
24. Hickman, H. D., K. Takeda, C. N. Skon, F. R. Murray, S. E. Hensley, J. Loomis, G. N. Barber, J. R. Bennink, and J. W. Yewdell. 2008. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat. Immunol. 9:155-165.
25. Holtappels, R., V. Böhm, J. Podlech, and M. J. Reddehase. 2008. CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model. Med. Microbiol. Immunol. 197:125-134.
26. Holtappels, R., D. Gillert-Marien, D. Thomas, J. Podlech, P. Deegen, S. Herter, S. A. Oehrlein-Karpi, D. Strand, M. Wagner, and M. J. Reddehase. 2006. Cytomegalovirus encodes a positive regulator of antigen presentation. J. Virol. 80:7613-7624.
27. Holtappels, R., M. W. Munks, J. Podlech, and M. J. Reddehase. 2006. CD8 T-cell-based immunotherapy of cytomegalovirus disease in the mouse model of the immunocompromised bone marrow transplantation recipient, p. 383-418. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, Norfolk, United Kingdom.
28. Holtappels, R., J. Podlech, M.-F. Pahl-Seibert, M. Juelch, D. Thomas, C. O. Simon, M. Wagner, and M. J. Reddehase. 2004. Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J. Exp. Med. 199:131-136.
29. Holtappels, R., C. O. Simon, M. W. Munks, D. Thomas, P. Deegen, B. Kühnapfel, T. Däubner, S. F. Emde, J. Podlech, N. K. Grzimek, S. A. Oehrlein-Karpi, A. B. Hill, and M. J. Reddehase. 2008. Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination. J. Virol. 82:5781-5796.
30. d haplotype. J. Virol. 76:151-164.
31. Kavanagh, D. G., M. C. Gold, M. Wagner, U. H. Koszinowski, and A. B. Hill. 2001. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med. 194:967-977.
32. Kavanagh, D. G., U. H. Koszinowski, and A. B. Hill. 2001. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment. J. Immunol. 167:3894-3902.
33. Kleijnen, M. F., J. B. Huppa, P. Lucin, S. Mukherjee, H. Farrell, A. E. Campbell, U. H. Koszinowski, A. B. Hill, and H. Ploegh. 1997. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16:685-694.
34. + T lymphocytes and NK cells in vivo. Nat. Immunol. 3:529-535.
35. Krmpotic, A., M. Messerle, I. Crnkovic-Mertens, B. Polic, S. Jonjic, and U. H. Koszinowski. 1999. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J. Exp. Med. 190:1285-1295.
36. Kurz, S. K., M. Rapp, H.-P. Steffens, N. K. A. Grzimek, S. Schmalz, and M. J. Reddehase. 1999. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol. 73:482-494.
37. Kurz, S. K., H.-P. Steffens, A. Mayer, J. R. Harris, and M. J. Reddehase. 1997. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:2980-2987.
38. Lenac, T., J. Arapovic, L. Traven, A. Krmpotic, and S. Jonjic. 2008. Murine cytomegalovirus regulation of NKG2D ligands. Med. Microbiol. Immunol. 197:159-166.
39. Lilley, B. N., and H. L. Ploegh. 2005. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol. Rev. 207:126-144.
40. Lodoen, M., K. Ogasawara, J. A. Hamerman, H. Arase, J. P. Houchins, E. S. Mocarski, and L. L. Lanier. 2003. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197:1245-1253.
41. Loureiro, J., and H. L. Ploegh. 2006. Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv. Immunol. 92:225-305.
42. Lu, X., A. K. Pinto, A. M. Kelly, K. S. Cho, and A. B. Hill. 2006. Murine cytomegalovirus interference with antigen presentation contributes to the inability of CD8 T cells to control virus in the salivary gland. J. Virol. 80:4200-4202.
43. Mathys, S., T. Schroeder, J. Ellwart, U. H. Koszinowski, M. Messerle, and U. Just. 2003. Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J. Infect. Dis. 187:988-999.
44. Moutaftsi, M., A. M. Mehl, L. K. Borysiewicz, and Z. Tabi. 2002. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99:2913-2921.
45. Munks, M. W., A. K. Pinto, C. M. Doom, and A. B. Hill. 2007. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J. Immunol. 178:7235-7241.
46. + T cells by infected dendritic cells in vivo. Nat. Immunol. 3:265-271.
47. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-α-/β and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746-4756.
48. Pahl-Seibert, M.-F., M. Juelch, J. Podlech, D. Thomas, P. Deegen, M. J. Reddehase, and R. Holtappels. 2005. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. J. Virol. 79:5400-5413.
49. Pinto, A. K., and A. B. Hill. 2005. Viral interference with antigen presentation to CD8 T cells: lessons from cytomegalovirus. Viral Immunol. 18:434-444.
50. Pinto, A. K., M. W. Munks, U. H. Koszinowski, and A. B. Hill. 2006. Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J. Immunol. 177:3225-3234.
51. Ploegh, H. 1998. Viral strategies of immune evasion. Science 280:248-253.
52. Podlech, J., R. Holtappels, N. K. A. Grzimek, and M. J. Reddehase. 2002. Animal models: murine cytomegalovirus, p. 493-525. In S. H. E. Kaufmann and D. Kabelitz (ed.), Methods in microbiology, 2nd ed., vol. 32. Academic Press, San Diego, CA.
53. Raftery, M. J., M. Schwab, S. M. Eibert, Y. Samstag, H. Walczak, and G. Schönrich. 2001. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15:997-1009.
54. Reddehase, M. J. 2002. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2:831-844.
55. Reddehase, M. J., J. B. Rothbard, and U. H. Koszinowski. 1989. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337:651-653.
56. Reddehase, M. J., C. O. Simon, J. Podlech, and R. Holtappels. 2004. Stale-mating a clever opportunist: lessons from murine cytomegalovirus. Hum. Immunol. 65:446-455.
57. Reusch, U., O. Bernhard, U. H. Koszinowski, and P. Schu. 2002. AP-1A and AP-3A lysosomal sorting functions. Traffic 3:752-761.
58. Reusch, U., W. Muranyi, P. Lucin, H. G. Burgert, H. Hengel, and U. H. Koszinowski. 1999. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18:1081-1091.
59. Robbins, S. H., G. Bessou, A. Cornillon, N. Zucchini, B. Rupp, Z. Ruzsics, T. Sacher, E. Tomasello, E. Vivier, U. H. Koszinowski, and Marc Dalod. 2007. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathogens 3:1152-1164.
60. Schnorrer, P., G. M. Behrens, N. S. Wilson, J. L. Pooley, C. M. Smith, D. EI-Sukkari, G. Davey, F. Kupresanin, M. Li, E. Maraskovsky, G. T. Belz, F. R. Carbone, K. Shortman, W. R. Heath, and J. A. Villadangos. 2006. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl. Acad. Sci. USA 103:10729-10734.
61. Simon, C. O., R. Holtappels, H.-M. Tervo, V. Böhm, T. Däubner, S. A. Oehrlein-Karpi, B. Kühnapfel, A. Renzaho, D. Strand, J. Podlech, M. J. Reddehase, and N. K. A. Grzimek. 2006. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J. Virol. 80:10436-10456.
62. Simon, C. O., B. Kühnapfel, M. J. Reddehase, and N. K. Grzimek. 2007. Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription. J. Virol. 81:7805-7810.
63. Simon, C. O., C. K. Seckert, D. Dreis, M. J. Reddehase, and N. K. Grzimek. 2005. Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J. Virol. 79:326-340.
64. Smith, H. R., J. W. Heusel, I. K. Metha, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel., A. A. Scalzo, D. H. Fremont, and W. M. Yokoyama. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99:8826-8831.
65. Streblow, D. N., S. M. Varnum, R. D. Smith, and J. A. Nelson. 2006. A proteomics analysis of human cytomegalovirus particles, p. 91-110. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, Norfolk, United Kingdom.
66. Tortorella, D., B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18:861-926.
67. Villadangos, J. A., W. R. Heath, and F. R. Carbone. 2007. Outside looking in: the inner workings of the cross-presentation pathways within dendritic cells. Trends Immunol. 28:45-47.
68. Wagner, M., A. Gutermann, J. Podlech, M. J. Reddehase, and U. H. Koszinowski. 2002. MHC class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196:805-816.
69. Wagner, M., S. Jonjic, U. H. Koszinowski, and M. Messerle. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060.
70. Wilhelmi, V., C. O. Simon, J. Podlech, V. Böhm, T. Däubner, S. Emde, D. Strand, A. Renzaho, N. A. W. Lemmermann, C. K. Seckert, M. J. Reddehase, and N. K. A. Grzimek. 2008. Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissues. J. Virol. 82:9900-9916.
71. Yewdell, J. W., and A. B. Hill. 2002. Viral interference with antigen presentation. Nat. Immunol. 3:1019-1025.
72. Ziegler, H., R. Thäle, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farrell, W. Rawlinson, and U. H. Koszinowski. 1997. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57-66.